Phospholipid ether (PLE)

Phospholipid ethers (PLEs), also known as ether phospholipids or alkylphospholipids, are a specialized class of lipids characterized by an ether linkage at the sn-1 position of the glycerol backbone (PubChem). These molecules occur naturally in trace amounts in healthy tissues but are found in significantly higher concentrations in malignant cells, serving as a unique biochemical signature for cancer (Weichert et al., 2014, Science Translational Medicine). PLEs are considered a therapeutic target and delivery platform because they selectively accumulate and are retained within the lipid rafts of cancer cell membranes, whereas healthy cells efficiently metabolize and clear them. This differential uptake has led to the development of phospholipid-drug conjugates (PDCs) and targeted radiopharmaceuticals, such as iopofosine I-131, which exploit the PLE 'uptake pathway' to deliver cytotoxic payloads directly to tumors (OncLive, 2020). Beyond acting as delivery vehicles, PLEs can directly induce programmed cell death by inhibiting pro-survival signaling pathways like Akt/PI3K or by promoting the recruitment of death receptors such as Fas/CD95 into membrane rafts (Gajate & Mollinedo, 2014, Pharmacology & Therapeutics). Their broad-spectrum uptake across diverse tumor types makes them a versatile platform for both cancer imaging and therapy.

Other names

Ether phospholipidAlkylphospholipidAlkylphosphocholineAntitumor lipidEther-linked phospholipidAlkyl-lysophospholipidEther lipid

Phospholipid ethers (PLEs) target cancer cells by selectively accumulating in cholesterol-rich membrane microdomains known as lipid rafts, which are present at significantly higher densities in malignant cells compared to normal tissues (Weichert et al., 2014). Once incorporated, synthetic PLE analogs act as therapeutic agents by interfering with survival signaling pathways, particularly the PI3K/Akt/mTOR axis, and by inducing the translocation of the Fas/CD95 death receptor into lipid rafts to trigger intracellular apoptosis (Gajate & Mollinedo, 2014). Additionally, PLEs serve as a delivery platform in the form of phospholipid-drug conjugates (PDCs), where the PLE moiety facilitates the transport of cytotoxic payloads—such as the radioisotope Iodine-131—directly into the tumor cell membrane and cytoplasm (Cellectar Biosciences).